These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 30149128

  • 21. TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp- and BCRP-mediated efflux.
    D'Cunha R, Bae S, Murry DJ, An G.
    Biopharm Drug Dispos; 2016 Oct; 37(7):397-408. PubMed ID: 27418107
    [Abstract] [Full Text] [Related]

  • 22. Overcoming ABCG2-mediated drug resistance with imidazo-[1,2-b]-pyridazine-based Pim1 kinase inhibitors.
    Darby RA, Unsworth A, Knapp S, Kerr ID, Callaghan R.
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):853-64. PubMed ID: 26351135
    [Abstract] [Full Text] [Related]

  • 23. Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux.
    Volk EL, Rohde K, Rhee M, McGuire JJ, Doyle LA, Ross DD, Schneider E.
    Cancer Res; 2000 Jul 01; 60(13):3514-21. PubMed ID: 10910063
    [Abstract] [Full Text] [Related]

  • 24. Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets.
    Puris E, Gynther M, de Lange ECM, Auriola S, Hammarlund-Udenaes M, Huttunen KM, Loryan I.
    Mol Pharm; 2019 Jul 01; 16(7):3261-3274. PubMed ID: 31180686
    [Abstract] [Full Text] [Related]

  • 25. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
    Honda Y, Ushigome F, Koyabu N, Morimoto S, Shoyama Y, Uchiumi T, Kuwano M, Ohtani H, Sawada Y.
    Br J Pharmacol; 2004 Dec 01; 143(7):856-64. PubMed ID: 15504753
    [Abstract] [Full Text] [Related]

  • 26. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A, Maeda K, Kamiyama E, Sugiyama D, Kondo T, Shiroyanagi Y, Nakazawa H, Okano T, Adachi M, Schuetz JD, Adachi Y, Hu Z, Kusuhara H, Sugiyama Y.
    Drug Metab Dispos; 2007 Dec 01; 35(12):2166-76. PubMed ID: 17823233
    [Abstract] [Full Text] [Related]

  • 27. The Role of Transporters in Future Chemotherapy.
    Huttunen J, Huttunen KM.
    Chimia (Aarau); 2022 May 25; 76(5):454-459. PubMed ID: 38069717
    [Abstract] [Full Text] [Related]

  • 28. Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound.
    Bornmann WG, Roepe PD.
    Biochemistry; 1994 Oct 25; 33(42):12665-75. PubMed ID: 7918493
    [Abstract] [Full Text] [Related]

  • 29. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
    Mandíková J, Volková M, Pávek P, Česnek M, Janeba Z, Kubíček V, Trejtnar F.
    Toxicology; 2013 Sep 15; 311(3):135-46. PubMed ID: 23856525
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
    Breedveld P, Zelcer N, Pluim D, Sönmezer O, Tibben MM, Beijnen JH, Schinkel AH, van Tellingen O, Borst P, Schellens JH.
    Cancer Res; 2004 Aug 15; 64(16):5804-11. PubMed ID: 15313923
    [Abstract] [Full Text] [Related]

  • 31. Amino acid ester prodrugs conjugated to the α-carboxylic acid group do not display affinity for the L-type amino acid transporter 1 (LAT1).
    Rautio J, Kärkkäinen J, Huttunen KM, Gynther M.
    Eur J Pharm Sci; 2015 Jan 23; 66():36-40. PubMed ID: 25305508
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell line.
    Rhee MS, Schneider E.
    Biochem Pharmacol; 2005 Jan 01; 69(1):123-32. PubMed ID: 15588721
    [Abstract] [Full Text] [Related]

  • 34. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
    Wiriyasermkul P, Nagamori S, Tominaga H, Oriuchi N, Kaira K, Nakao H, Kitashoji T, Ohgaki R, Tanaka H, Endou H, Endo K, Sakurai H, Kanai Y.
    J Nucl Med; 2012 Aug 01; 53(8):1253-61. PubMed ID: 22743251
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.
    Mo L, Pospichalova V, Huang Z, Murphy SK, Payne S, Wang F, Kennedy M, Cianciolo GJ, Bryja V, Pizzo SV, Bachelder RE.
    PLoS One; 2015 Aug 01; 10(7):e0131579. PubMed ID: 26148191
    [Abstract] [Full Text] [Related]

  • 37. Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2).
    Tan KW, Cooney J, Jensen D, Li Y, Paxton JW, Birch NP, Scheepens A.
    Mol Nutr Food Res; 2014 Nov 01; 58(11):2099-110. PubMed ID: 25044854
    [Abstract] [Full Text] [Related]

  • 38. Systemic and Brain Pharmacokinetics of Perforin Inhibitor Prodrugs.
    Gynther M, Pickering DS, Spicer JA, Denny WA, Huttunen KM.
    Mol Pharm; 2016 Jul 05; 13(7):2484-91. PubMed ID: 27266990
    [Abstract] [Full Text] [Related]

  • 39. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F, Lu P, Cortés-Selva F, Pérez-Victoria JM, Jiménez IA, Ravelo AG, Sharom FJ, Gamarro F, Castanys S.
    Cancer Res; 2004 Oct 01; 64(19):7130-8. PubMed ID: 15466210
    [Abstract] [Full Text] [Related]

  • 40. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
    Oshida K, Shimamura M, Seya K, Ando A, Miyamoto Y.
    Eur J Drug Metab Pharmacokinet; 2017 Feb 01; 42(1):117-128. PubMed ID: 26961540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.